FAKTOR-OPTIONSSCHEIN - INCYTE CO. Share Price

DE000SD416T4

Market Closed - Boerse Frankfurt Warrants 20:51:24 20/05/2024 BST
5.22 ^EUR	+0.58%

Current month	-39.37%
1 month	-34.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	05-15
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	05-14	BU
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	05-13	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	05-13	MT

More news

Quotes 5-day view

Date	Price	Change
20/05/24	5.23	+0.77%
17/05/24	5.19	-2.08%
16/05/24	5.3	+2.32%
15/05/24	5.18	-0.38%
14/05/24	5.2	+1.76%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 08:51 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SD416T
ISIN	DE000SD416T4
Date issued	29/03/2021
Strike	79.94 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.47 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	16.19 €
Lowest since issue	1.85 €
Spread	0.02 €
Spread %	0.38%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.19 USD

Average target price

73.35 USD

Spread / Average Target

+28.26%

Consensus